Molecular Pharmacology of Somatostatin Receptors

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1994 Nov 1

PMID 7870182

Citations 27

Authors

D Hoyer

H Lubbert

C Bruns

Affiliations

Soon will be listed here.

Abstract

The neuropeptide somatostatin (SRIF) is widely expressed in the brain and in the periphery in two main forms, SRIF-14 and SRIF-28. Similarly, the presence of SRIF receptors throughout the whole body has been reported. SRIF produces a variety of effects including modulation of hormone release (e.g. GH, glucagon, insulin), of neurotransmitter release (e.g. acetylcholine, dopamine, 5-HT), and its own release is modulated by many neurotransmitters. SRIF affects cognitive and behavioural processes, the endocrine system, the gastrointestinal tract and the cardiovascular system and also has tumor growth inhibiting effects. Initially, two classes of SRIF receptors have been proposed on the basis of biochemical and functional studies. However, the recent cloning of five putative SRIF receptor subtypes which belong to the G-protein coupled receptor superfamily suggests that SRIF mediates its various effects via a whole family of receptors. Here we review, in this new context, the molecular pharmacology of the SRIF receptor subtypes present in the brain and in the periphery, and address the question of nomenclature of SRIF receptors.

Citing Articles

Structural basis for activation of somatostatin receptor 5 by cyclic neuropeptide agonists.

Li J, You C, Li Y, Li C, Fan W, Chen Z Proc Natl Acad Sci U S A. 2024; 121(26):e2321710121.

PMID: 38885377 PMC: 11214081. DOI: 10.1073/pnas.2321710121.

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-DOTATOC PET/CT.

Jahn U, Ilan E, Velikyan I, Fross-Baron K, Lubberink M, Sundin A EJNMMI Res. 2021; 11(1):118.

PMID: 34822040 PMC: 8617112. DOI: 10.1186/s13550-021-00860-0.

The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?.

Guarnotta V, Martini C, Davi M, Pizza G, Colao A, Faggiano A Endocrine. 2017; 60(1):15-27.

PMID: 29019150 DOI: 10.1007/s12020-017-1420-4.

Copper-64 Radiopharmaceuticals for Oncologic Imaging.

Holland J, Ferdani R, Anderson C, Lewis J PET Clin. 2016; 4(1):49-67.

PMID: 27156895 PMC: 4961094. DOI: 10.1016/j.cpet.2009.04.013.

Cross-talk and modulation of signaling between somatostatin and growth factor receptors.

Kumar U Endocrine. 2011; 40(2):168-80.

PMID: 21870170 DOI: 10.1007/s12020-011-9524-8.

References

Vanetti M, Vogt G, Hollt V . The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett. 1993; 331(3):260-6. DOI: 10.1016/0014-5793(93)80349-y. View

Robbins R, Landon R . Somatostatin release from cerebral cortical cells: influence of amino acid neurotransmitters. Brain Res. 1983; 273(2):374-8. DOI: 10.1016/0006-8993(83)90866-1. View

Watson T, Pittman Q . Pharmacological evidence that somatostatin activates the m-current in hippocampal pyramidal neurons. Neurosci Lett. 1988; 91(2):172-6. DOI: 10.1016/0304-3940(88)90763-x. View

Reubi J, Perrin M, Rivier J, Vale W . High affinity binding sites for somatostatin to rat pituitary. Biochem Biophys Res Commun. 1982; 105(4):1538-45. DOI: 10.1016/0006-291x(82)90963-9. View

Tran V, Beal M, Martin J . Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science. 1985; 228(4698):492-5. DOI: 10.1126/science.2858917. View

Nemeth E, Cooper J . Effect of somatostatin on acetylcholine release from rat hippocampal synaptosomes. Brain Res. 1979; 165(1):166-70. DOI: 10.1016/0006-8993(79)90057-x. View

Rivier J, Brown M, Vale W . D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule. Biochem Biophys Res Commun. 1975; 65(2):746-51. DOI: 10.1016/s0006-291x(75)80208-7. View

Humphrey P, Hartig P, Hoyer D . A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci. 1993; 14(6):233-6. DOI: 10.1016/0165-6147(93)90016-d. View

Reubi J, Maurer R . Different ionic requirements for somatostatin receptor subpopulations in the brain. Regul Pept. 1986; 14(4):301-11. DOI: 10.1016/0167-0115(86)90172-2. View

10.

Vezzani A, Serafini R, Stasi M, Vigano G, Rizzi M, Samanin R . A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology. 1991; 30(4):345-52. DOI: 10.1016/0028-3908(91)90059-k. View

11.

Reubi J, Maurer R . Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary. Neuroscience. 1985; 15(4):1183-93. DOI: 10.1016/0306-4522(85)90261-1. View

12.

Cohen M, Rosing E, Wiley K, SLATER I . Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscle. Life Sci. 1978; 23(16):1659-64. DOI: 10.1016/0024-3205(78)90463-0. View

13.

Beal M, Mazurek M, Svendsen C, BIRD E, Martin J . Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease. Ann Neurol. 1986; 20(4):489-95. DOI: 10.1002/ana.410200408. View

14.

Reubi J, Rivier J, Perrin M, Brown M, Vale W . Specific high affinity binding sites for somatostatin-28 on pancreatic beta-cells: differences with brain somatostatin receptors. Endocrinology. 1982; 110(3):1049-51. DOI: 10.1210/endo-110-3-1049. View

15.

Reubi J, Krenning E, Lamberts S, Kvols L . In vitro detection of somatostatin receptors in human tumors. Digestion. 1993; 54 Suppl 1:76-83. DOI: 10.1159/000201082. View

16.

Reisine T, Zhang Y, Sekura R . Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells. J Pharmacol Exp Ther. 1985; 232(1):275-82. View

17.

Tapia-Arancibia L, ASTIER H . Pharmacological properties of the NMDA receptor involved in somatostatin release from cortical neurons. Eur J Pharmacol. 1990; 186(2-3):319-22. DOI: 10.1016/0014-2999(90)90452-c. View

18.

Tapia-Arancibia L, ASTIER H . Glutamate stimulates somatostatin release from diencephalic neurons in primary culture. Endocrinology. 1988; 123(5):2360-6. DOI: 10.1210/endo-123-5-2360. View

19.

Raynor K, OCarroll A, Kong H, Yasuda K, Mahan L, Bell G . Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol Pharmacol. 1993; 44(2):385-92. View

20.

Heiman M, Murphy W, Coy D . Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis. Neuroendocrinology. 1987; 45(6):429-36. DOI: 10.1159/000124788. View